To test if these differences in tumor cell binding translate into differences in functionality, the Jurkat-human-4-1BB-NFkB-luc2 reporter assay illustrated in Figure 1D was applied using the same tumor cell line panel as applied in the cell binding assay (Figure 1F, Supplementary Table S3). This evidence concerns the gene NFKB1 and neoplasm.